Coronavirus Disease COVID 19

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. COVID-19 is caused by one virus, called severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.
Plasma Donation and COVID-19

The COVID-19 pandemic revived interest in convalescent plasma therapy as a potential treatment, especially prior to the development of vaccines.

Read More

Overview

Feature Articles

Latest Coronavirus Disease COVID 19 News and Research

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Reopening of long-term care facilities is ‘an absolute necessity for our well-being’

Reopening of long-term care facilities is ‘an absolute necessity for our well-being’

Coronavirus deranges the immune system in complex and deadly ways

Coronavirus deranges the immune system in complex and deadly ways

To help farmworkers get Covid tests and vaccine, build trust and a safety net

To help farmworkers get Covid tests and vaccine, build trust and a safety net

Accidentally trashed, thawed or expired: reports of Covid vaccine spoilage

Accidentally trashed, thawed or expired: reports of Covid vaccine spoilage

Research looks at COVID vaccine hesitancy and refusal among the U.S. public

Research looks at COVID vaccine hesitancy and refusal among the U.S. public

Study suggests no protection against SARS-CoV-2 infection from recent exposure to HCoVs

Study suggests no protection against SARS-CoV-2 infection from recent exposure to HCoVs

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Wikipedia maintained high-quality COVID-19 coverage during first pandemic wave

Wikipedia maintained high-quality COVID-19 coverage during first pandemic wave

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant

COVID risk to households and teachers from in person schooling

COVID risk to households and teachers from in person schooling

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Genetic variation associated with COVID-19 outcome

Genetic variation associated with COVID-19 outcome

Low-cost, non-electric ventilator allows non-specialized workers to treat COVID-19 patients

Low-cost, non-electric ventilator allows non-specialized workers to treat COVID-19 patients

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Pharmacists discover active substances that block SARS-CoV-2 replication

Pharmacists discover active substances that block SARS-CoV-2 replication

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain